GLYCOMIMETICS INC's ticker is GLYC and the CUSIP is 38000Q102. A total of 31 filers reported holding GLYCOMIMETICS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $208,000 | +25.3% | 14,866 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $166,000 | +39.5% | 14,866 | -32.2% | 0.00% | – |
| Q1 2017 | $119,000 | -11.2% | 21,924 | 0.0% | 0.00% | -100.0% |
| Q4 2016 | $134,000 | -14.6% | 21,924 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $157,000 | -1.3% | 21,924 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $159,000 | +69.1% | 21,924 | +39.1% | 0.00% | – |
| Q1 2016 | $94,000 | +4.4% | 15,765 | 0.0% | 0.00% | – |
| Q4 2015 | $90,000 | +2.3% | 15,765 | 0.0% | 0.00% | – |
| Q3 2015 | $88,000 | -29.6% | 15,765 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $125,000 | -31.7% | 15,765 | -28.2% | 0.00% | 0.0% |
| Q1 2015 | $183,000 | +15.8% | 21,955 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $158,000 | +3.9% | 21,955 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $152,000 | -17.8% | 21,955 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $185,000 | -39.3% | 21,955 | +17.6% | 0.00% | 0.0% |
| Q1 2014 | $305,000 | – | 18,671 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,000,000 | $5,220,000 | 0.73% |
| NEA Management Company, LLC | 4,764,440 | $8,290,126 | 0.63% |
| Artal Group S.A. | 8,589,064 | $14,945 | 0.46% |
| BVF INC/IL | 9,544,262 | $16,607,016 | 0.46% |
| Sargent Investment Group, LLC | 108,000 | $187,920 | 0.05% |
| Intellectus Partners, LLC | 73,475 | $127,847 | 0.04% |
| XTX Topco Ltd | 29,998 | $52,197 | 0.01% |
| AXA S.A. | 1,631,509 | $2,838,826 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 1,149,656 | $1,999 | 0.01% |
| TOBIAS FINANCIAL ADVISORS, INC. | 15,000 | $26,100 | 0.01% |